Search research articles
Contact Us
Filters
Showing results (131-140 of 154) with videos related to
Page
of 16
Sort By:
Blood
|
October 25, 2001
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease
V Leblond, V Lévy, F Maloisel, et al.
Pediatrics
|
July 1, 1997
Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. The Children's Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC)
F Millot, A Robert, Y Bertrand, et al.
Leukemia
|
March 14, 2009
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
A Hochhaus, S G O'Brien, F Guilhot, et al.
Blood
|
August 10, 1999
Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial
T Facon, J L Harousseau, F Maloisel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques
J L Harousseau, B Witz, B Lioure, et al.
Blood
|
June 8, 2001
Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission
D Blaise, D Maraninchi, M Michallet, et al.
Leukemia
|
April 28, 2006
Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP)
F E Nicolini, S Corm, Q-H Lê, et al.
Bone Marrow Transplantation
|
June 12, 2002
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy
S Vigouroux, N Milpied, J M Andrieu, et al.
British Journal of Haematology
|
March 5, 2003
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries
Elisabeth Vandenberghe, Carmen Ruiz de Elvira, Fausto R Loberiza, et al.
Blood
|
November 5, 1997
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)
J L Harousseau, J Y Cahn, B Pignon, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 154) with videos related to
Sort By:
Page
of 16
Blood
|
October 25, 2001
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease
V Leblond, V Lévy, F Maloisel, et al.
Pediatrics
|
July 1, 1997
Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. The Children's Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC)
F Millot, A Robert, Y Bertrand, et al.
Leukemia
|
March 14, 2009
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
A Hochhaus, S G O'Brien, F Guilhot, et al.
Blood
|
August 10, 1999
Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial
T Facon, J L Harousseau, F Maloisel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques
J L Harousseau, B Witz, B Lioure, et al.
Blood
|
June 8, 2001
Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission
D Blaise, D Maraninchi, M Michallet, et al.
Leukemia
|
April 28, 2006
Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP)
F E Nicolini, S Corm, Q-H Lê, et al.
Bone Marrow Transplantation
|
June 12, 2002
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy
S Vigouroux, N Milpied, J M Andrieu, et al.
British Journal of Haematology
|
March 5, 2003
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries
Elisabeth Vandenberghe, Carmen Ruiz de Elvira, Fausto R Loberiza, et al.
Blood
|
November 5, 1997
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)
J L Harousseau, J Y Cahn, B Pignon, et al.
Page
of 16